COMPLETED

An Observational Study to Assess Malnutrition Risk

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a prospective, observational study for assessing malnutrition risk and its characteristics among children aged 1 to 5 living in under-resourced communities in Colombia. There is also a qualitative component that seeks to gain caregiver, community health worker (CHW), public health professional (PHP), and non-for-profit organization (NGO) insights related to malnutrition risk.

Official Title

CROSS: Colombia's Potential Realized: an Observational Study for Stunting

Quick Facts

Study Start:2024-12-09
Study Completion:2025-07-25
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06709001

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:1 Year to 5 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Children aged 1-5 years
  2. * Children's legal guardian agrees to participate in the study
  3. * Full term pregnancy
  4. * Residence in study area attending Children International (NGO) centers
  1. * Children who have current medical conditions requiring hospitalization: gastrointestinal tract infections or inflammatory bowel disease; active tuberculosis; acute hepatitis B or C; human immunodeficiency virus OR malignancy; cystic fibrosis; immunodeficiency syndromes, congenital abnormalities of the respiratory tract, such as lung and respiratory cilia; an unsuspected foreign body in the respiratory tract; asthma; and known metabolic disorders, renal impairment, or rheumatic diseases and diabetes,
  2. * Congenital condition
  3. * Children with disabilities such as cerebral palsy, autism spectrum disorder, neurodegenerative disorders
  4. * Children with chronic or acute infections e.g. HIV, malaria
  5. * Children who are taking medications or other agents that could potentially affect body weight, including diuretics, appetite stimulants, steroids, and growth hormones.
  6. * Children already enrolled in a nutrition program/intervention that includes a supplement

Contacts and Locations

Principal Investigator

Amy Sharn, MS, RDN, LD
STUDY_CHAIR
Abbott

Study Locations (Sites)

Children International
Kansas City, Missouri, 64121
United States

Collaborators and Investigators

Sponsor: Abbott Nutrition

  • Amy Sharn, MS, RDN, LD, STUDY_CHAIR, Abbott

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12-09
Study Completion Date2025-07-25

Study Record Updates

Study Start Date2024-12-09
Study Completion Date2025-07-25

Terms related to this study

Additional Relevant MeSH Terms

  • Malnutrition